Answers are grounded in this paper and cite their sources.
Heatstroke-triggered neurological complications are escalating year by year. Although rare, GBS (Guillain-Barré syndrome, GBS) represents a life-threatening sequel of heat-stroke, arising from severe dysfunction of the nervous system. Its pathophysiology unfolds through a tangled cascade of inflammatory pathways and oxidative stress, culminating in diffuse peripheral neuropathies and mortality. Epidemiologically, Guillain-Barré syndrome following heat stroke displays notable demographic variability, with advanced age and male sex emerging as prominent risk factors. Diagnostic approaches hinge upon an integration of biomarkers (e.g., cerebrospinal fluid (CSF) analysis revealing a protein-cell dissociation phenomenon), electrophysiological assessments (e.g., motor and sensory nerve conduction studies, F-wave evaluations, and needle electromyography), and clinical criteria, though standardized definitions remain elusive. Treatment strategies encompass immunotherapy (e.g., intravenous immunoglobulin, plasma exchange), glucocorticoid, respiratory function management, nutritional support, rehabilitation, etc. Cases of Guillain–Barré syndrome secondary to heatstroke have been increasingly reported year by year. Currently, a standardized therapeutic protocol for this complication has yet to be established. This article offers a thorough grounded in current knowledge and practical case rescue experience.
No takes yet. Share an insight, caveat, or question.
Pang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: